Abt missed sales because: 1.) Diabetic sales neg. growth. 2.) Established Pharm Sales in mature markets (ie. Europe) show no growth. 3.) Pediatric sales in China, Vietnam and Saudi Arabia, have negatively been impacted in the 3rd and 4th Quarters. First and Second Qtr 2014 EPS are very low, and it looks like Abbott is bring into US 2014 foreign earnings and paying US taxes to buy back 3% of Abbott outstanding share in order to make 2014 EPS targets.